141 related articles for article (PubMed ID: 38282155)
21. Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer.
Yong W; Yu D; Jun Z; Yachen D; Weiwei W; Midie X; Xingzhu J; Xiaohua W
Cell Death Dis; 2018 Aug; 9(9):861. PubMed ID: 30154460
[TBL] [Abstract][Full Text] [Related]
22. miR-451a suppresses the development of breast cancer via targeted inhibition of CCND2.
Zhang H; Chen P; Yang J
Mol Cell Probes; 2020 Dec; 54():101651. PubMed ID: 32828867
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
24. CircSETDB1 knockdown inhibits the malignant progression of serous ovarian cancer through miR-129-3p-dependent regulation of MAP3K3.
Li B; Zhang L
J Ovarian Res; 2021 Nov; 14(1):160. PubMed ID: 34789310
[TBL] [Abstract][Full Text] [Related]
25. MiR-96-5p promotes breast cancer migration by activating MEK/ERK signaling.
Qin WY; Feng SC; Sun YQ; Jiang GQ
J Gene Med; 2020 Aug; 22(8):e3188. PubMed ID: 32196830
[TBL] [Abstract][Full Text] [Related]
26. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
[TBL] [Abstract][Full Text] [Related]
27. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
Zhang P; He M; Zeng Y; Cai X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
[TBL] [Abstract][Full Text] [Related]
28. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
[TBL] [Abstract][Full Text] [Related]
29. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA‑143‑3p suppresses cell growth and invasion in laryngeal squamous cell carcinoma via targeting the k‑Ras/Raf/MEK/ERK signaling pathway.
Zhang F; Cao H
Int J Oncol; 2019 Feb; 54(2):689-701. PubMed ID: 30535502
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1.
Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
[TBL] [Abstract][Full Text] [Related]
32. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
[TBL] [Abstract][Full Text] [Related]
33. Long Noncoding RNA TP53TG1 Contributes to Radioresistance of Glioma Cells Via miR-524-5p/RAB5A Axis.
Gao W; Qiao M; Luo K
Cancer Biother Radiopharm; 2021 Sep; 36(7):600-612. PubMed ID: 32762546
[No Abstract] [Full Text] [Related]
34. microRNA-324-3p suppresses the aggressive ovarian cancer by targeting
Li F; Liang Z; Jia Y; Zhang P; Ling K; Wang Y; Liang Z
Bioengineered; 2022 May; 13(5):12030-12044. PubMed ID: 35549643
[TBL] [Abstract][Full Text] [Related]
35. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
Yu X; Huang M; Yang G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
[TBL] [Abstract][Full Text] [Related]
36. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
37. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.
Ghousein A; Mosca N; Cartier F; Charpentier J; Dupuy JW; Raymond AA; Bioulac-Sage P; Grosset CF
Liver Int; 2020 Jan; 40(1):240-251. PubMed ID: 31612616
[TBL] [Abstract][Full Text] [Related]
38. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
[TBL] [Abstract][Full Text] [Related]
39. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells.
Liu P; Wilson MJ
J Cell Physiol; 2012 Feb; 227(2):867-76. PubMed ID: 21898400
[TBL] [Abstract][Full Text] [Related]
40. MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Wu RS; Qiu EH; Zhu JJ; Wang JR; Lin HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):150-157. PubMed ID: 29364482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]